Your browser doesn't support javascript.
loading
Performance evaluation of automated white matter hyperintensity segmentation algorithms in a multicenter cohort on cognitive impairment and dementia.
Gaubert, Malo; Dell'Orco, Andrea; Lange, Catharina; Garnier-Crussard, Antoine; Zimmermann, Isabella; Dyrba, Martin; Duering, Marco; Ziegler, Gabriel; Peters, Oliver; Preis, Lukas; Priller, Josef; Spruth, Eike Jakob; Schneider, Anja; Fliessbach, Klaus; Wiltfang, Jens; Schott, Björn H; Maier, Franziska; Glanz, Wenzel; Buerger, Katharina; Janowitz, Daniel; Perneczky, Robert; Rauchmann, Boris-Stephan; Teipel, Stefan; Kilimann, Ingo; Laske, Christoph; Munk, Matthias H; Spottke, Annika; Roy, Nina; Dobisch, Laura; Ewers, Michael; Dechent, Peter; Haynes, John Dylan; Scheffler, Klaus; Düzel, Emrah; Jessen, Frank; Wirth, Miranka.
Affiliation
  • Gaubert M; German Center for Neurodegenerative Diseases, Dresden, Germany.
  • Dell'Orco A; Department of Neuroradiology, Rennes University Hospital (CHU), Rennes, France.
  • Lange C; German Center for Neurodegenerative Diseases, Dresden, Germany.
  • Garnier-Crussard A; Department of Neuroradiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Zimmermann I; German Center for Neurodegenerative Diseases, Dresden, Germany.
  • Dyrba M; Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Duering M; Clinical and Research Memory Center of Lyon, Lyon Institute for Elderly, Hospices Civils de Lyon, Lyon, France.
  • Ziegler G; Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders," Institut Blood and Brain @ Caen-Normandie, Caen, France.
  • Peters O; Neuroscience Research Centre of Lyon, INSERM 1048, CNRS 5292, Lyon, France.
  • Preis L; German Center for Neurodegenerative Diseases, Dresden, Germany.
  • Priller J; German Center for Neurodegenerative Diseases, Rostock, Germany.
  • Spruth EJ; Department of Biomedical Engineering, Medical Image Analysis Center (MIAC) and qbig, University of Basel, Basel, Switzerland.
  • Schneider A; German Center for Neurodegenerative Diseases, Magdeburg, Germany.
  • Fliessbach K; German Center for Neurodegenerative Diseases, Berlin, Germany.
  • Wiltfang J; Department of Psychiatry, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Schott BH; Department of Psychiatry, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Maier F; German Center for Neurodegenerative Diseases, Berlin, Germany.
  • Glanz W; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Buerger K; Centre for Clinical Brain Sciences, University of Edinburgh and UK Dementia Research Institute (DRI), Edinburgh, United Kingdom.
  • Janowitz D; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany.
  • Perneczky R; German Center for Neurodegenerative Diseases, Berlin, Germany.
  • Rauchmann BS; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Teipel S; German Center for Neurodegenerative Diseases, Bonn, Germany.
  • Kilimann I; Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn Medical Center, Bonn, Germany.
  • Laske C; German Center for Neurodegenerative Diseases, Bonn, Germany.
  • Munk MH; Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn Medical Center, Bonn, Germany.
  • Spottke A; German Center for Neurodegenerative Diseases, Göttingen, Germany.
  • Roy N; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Göttingen, Germany.
  • Dobisch L; Department of Medical Sciences, Neurosciences and Signaling Group, Institute of Biomedicine (iBiMED), University of Aveiro, Aveiro, Portugal.
  • Ewers M; German Center for Neurodegenerative Diseases, Göttingen, Germany.
  • Dechent P; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Göttingen, Germany.
  • Haynes JD; Leibniz Institute for Neurobiology, Magdeburg, Germany.
  • Scheffler K; Department of Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany.
  • Düzel E; German Center for Neurodegenerative Diseases, Magdeburg, Germany.
  • Jessen F; German Center for Neurodegenerative Diseases, Munich, Germany.
  • Wirth M; Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich (LMU), Munich, Germany.
Front Psychiatry ; 13: 1010273, 2022.
Article in En | MEDLINE | ID: mdl-36713907
ABSTRACT

Background:

White matter hyperintensities (WMH), a biomarker of small vessel disease, are often found in Alzheimer's disease (AD) and their advanced detection and quantification can be beneficial for research and clinical applications. To investigate WMH in large-scale multicenter studies on cognitive impairment and AD, appropriate automated WMH segmentation algorithms are required. This study aimed to compare the performance of segmentation tools and provide information on their application in multicenter research.

Methods:

We used a pseudo-randomly selected dataset (n = 50) from the DZNE-multicenter observational Longitudinal Cognitive Impairment and Dementia Study (DELCODE) that included 3D fluid-attenuated inversion recovery (FLAIR) images from participants across the cognitive continuum. Performances of top-rated algorithms for automated WMH segmentation [Brain Intensity Abnormality Classification Algorithm (BIANCA), lesion segmentation toolbox (LST), lesion growth algorithm (LGA), LST lesion prediction algorithm (LPA), pgs, and sysu_media] were compared to manual reference segmentation (RS).

Results:

Across tools, segmentation performance was moderate for global WMH volume and number of detected lesions. After retraining on a DELCODE subset, the deep learning algorithm sysu_media showed the highest performances with an average Dice's coefficient of 0.702 (±0.109 SD) for volume and a mean F1-score of 0.642 (±0.109 SD) for the number of lesions. The intra-class correlation was excellent for all algorithms (>0.9) but BIANCA (0.835). Performance improved with high WMH burden and varied across brain regions.

Conclusion:

To conclude, the deep learning algorithm, when retrained, performed well in the multicenter context. Nevertheless, the performance was close to traditional methods. We provide methodological recommendations for future studies using automated WMH segmentation to quantify and assess WMH along the continuum of cognitive impairment and AD dementia.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Psychiatry Year: 2022 Document type: Article Affiliation country: Alemania

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Psychiatry Year: 2022 Document type: Article Affiliation country: Alemania
...